Fulfilling. Energizing. Brave. Empowering. Invigorating. Meaningful.
These are just some of the words the women of Agios use to describe what it’s like to work here. Developing breakthrough medicines for patients with cancer and rare genetic diseases is incredibly important, and so difficult. It takes great science. But it also takes an environment where people care – about the work, about each other, and about different perspectives – so they can flourish.
We care. A lot. Patients are counting on us, and we’re driven by a sense of urgency to help. We challenge ourselves to think big and welcome different perspectives and backgrounds. And we deliver. We have two approved oncology precision medicines and multiple first-in-class investigational therapies in development. So far.
And through it all, we are propelled by our connections. We believe in our people to be…just who they are. We believe in our work and in each other – in enjoying this journey together so that we can achieve the Other Side of Possible.
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. Our focus on people and culture comes from our OSOP (Other Side of Possible) philosophy. It speaks to our ability to find the sweet spot between exhilaration and anxiety – and to do it while being respectful, kind and connected with each other.
We’re a science-driven research organization with the patient at the center of all we do. We have built a discovery platform on our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic diseases and metabolic immuno-oncology. We take a systems biology approach to deeply understand disease states, drive the discovery and validation of novel therapeutic targets, and define patient selection strategies. It’s all done with the goal of increasing the probability that our experimental medicines will have the desired therapeutic effect.